SCHEMBL7181005

SCHEMBL7181005

CC1C(NC(=O)c2ccc(-c3cccc(O)c3)[nH]2)C2CCN1CC2

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
MLLT1 Q03111 4/20 0.40
MLLT3 P42568 2/20 0.40
ALDH1A1 P00352 2/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
CHRNB2 P17787 5/20 0.33
CHRNA4 P43681 5/20 0.33
PTPN1 P18031 1/20 0.33
CHRNA7 P36544 3/20 0.33
PIK3CD O00329 2/20 0.33
PIK3CA P42336 2/20 0.33
PIK3CB P42338 2/20 0.33
PIK3CG P48736 2/20 0.33
WNT3A P56704 1/20 0.33
CHRM3 P20309 2/20 0.32
GSK3B P49841 1/20 0.32
MAPK14 Q16539 1/20 0.32
MAPT P10636 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7132559 1.00 MLLT1 (0.40) MLLT1MLLT3ALDH1A1L3MBTL1CHRNB2
SCHEMBL7129660 0.90 CHRNA7 (0.38) ALDH1A1CHRNB2CHRNA4PTPN1CHRNA7
SCHEMBL7117473 0.89 FLT3 (0.37) ALDH1A1L3MBTL1CHRNB2CHRNA4PTPN1
SCHEMBL7124994 0.89 PTPN1 (0.35) ALDH1A1L3MBTL1CHRNB2CHRNA4PTPN1
SCHEMBL7123200 0.89 L3MBTL3 (0.37) ALDH1A1L3MBTL1CHRNB2CHRNA4PTPN1
SCHEMBL7590680 0.89 CHRNB2 (0.40) ALDH1A1CHRNB2CHRNA4PTPN1CHRNA7
SCHEMBL7597918 0.89 L3MBTL3 (0.37) ALDH1A1L3MBTL1CHRNB2CHRNA4PTPN1
SCHEMBL7121913 0.89 CHRNB2 (0.40) ALDH1A1CHRNB2CHRNA4PTPN1CHRNA7
SCHEMBL7225384 0.89 CHRNB2 (0.40) ALDH1A1CHRNB2CHRNA4CHRNA7CHRM3
SCHEMBL7130837 0.88 PTPN1 (0.44) ALDH1A1L3MBTL1CHRNB2CHRNA4PTPN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1311505-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE ( NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS ) PHARMACIA & UPJOHN COMPANY (US) 2003-05-21 EP claimed
WO-2002016355-A2 QUINUCLIDINE-SUBSTITUTED HETEROARYL MOIETIES FOR TREATMENT OF DISEASE (NICOTINIC) ACETYLCHOLINE RECEPTOR LIGANDS PHARMACIA & UPJOHN COMPANY (US) 2002-02-28 WO claimed